Chao Su

机构：Shandong University, Sichuan University, Zhongda Hospital Southeast University, Weihai Municipal Hospital, TCM-Intigrated Cancer Center of Southern Medical University, University of Hong Kong - Shenzhen Hospital, First Affiliated Hospital of Jinan University, Southern Medical University, University of Hong Kong · ORCID：0000-0002-1270-2064

发表论文 51 篇 · 总被引 1496 次 · h-index 20

代表论文

• Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis (2021 · Acta Biomaterialia · 被引 197)
• Anti-Inflammatory Activity of Mulberry Leaf Flavonoids In Vitro and In Vivo (2022 · International Journal of Molecular Sciences · 被引 68)
• Integrative analysis regarding the correlation between GAS2 family genes and human glioma prognosis (2021 · Cancer Medicine · 被引 45)
• High-dose VitC plus oncolytic adenoviruses enhance immunogenic tumor cell death and reprogram tumor immune microenvironment (2021 · Molecular Therapy · 被引 29)
• Genetic expression and mutational profile analysis in different pathologic stages of hepatocellular carcinoma patients (2021 · BMC Cancer · 被引 26)
• Integrating multi-omics technologies with traditional Chinese medicine to enhance cancer research and treatment (2025 · QJM · 被引 18)